Future nanomedical devices and systems will have strong potential to enable a broad range of aerospace and space applications. With further dimensional reductions in conjunction with the increased capabilities of nanoelectronics and artificial intelligence (AI), nanomedicine may facilitate the development of a wide array of advanced nanomedical diagnostic and therapeutic capabilities dedicated to the health and well being of future astronauts and space pioneers, the inhabitants of future Lunar and Mars colonies, and deep space explorers. These nanomedical innovations may form the core elements of advanced extravehicular space suits that have numerous advantages, such as continuous real-time health monitoring, virtually instantaneous in situ diagnostics, the auto-administration of therapeutics, and the capacities to address serious accidental circumstances and performance of emergency interventions.
WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19. Alpacas [...]
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing [...]
A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for [...]
The new technology behind Pfizer's and Moderna's coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine 'platform' they use transforms the [...]
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level. Scientists [...]
Virtual patients, vaccines, medicine-making biomachines and microneedles are examples of tech innovation that is meeting the moment to address the global health crisis. Health has been a strong [...]
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said Monday that an early peek [...]
The first coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis shows. The developers - Pfizer and BioNTech - described it as a "great [...]
Researchers led by the University at Buffalo (UB) have devised a new method that could enhance the effectiveness of vaccines against the novel coronavirus, the virus that is responsible for causing COVID-19. [...]
On March 17 this year, a man was taken to hospital in Israel suffering from a dry cough and a loss of sense of smell. He developed a fever and [...]
About NanoApps Medical Inc
NanoApps Medical, Inc. was incorporated by Frank Boehm in 2009 with the goal of developing advanced nanomedical diagnostic and therapeutic technologies for the benefit of individuals across both the developing and developed worlds.
The larger picture will be to eventually attain a situation of “Global Health Care Equivalency” (GHCE) where any individual on the planet may have access to the same advanced, high quality, and cost effective nanomedical diagnostic and therapeutic technologies, no matter where they happen to reside, or under what conditions they live. Boehm is now compiling a book that will articulate this grand vision.
Further, NanoApps Medical is ambitiously aiming to transition terrestrial nanomedicine to space applications to facilitate future Lunar and Mars missions, such as those being boldly planned by NASA and SpaceX.